IO Biotech, Inc. (IOBT) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 36.83M | 38.98M | 42.34M | 64.95M | 86.24M | 107.65M | 124.13M | 147.25M | 168.25M | 113.04M | 132.27M | 148.22M |
| Cash & Short-Term Investments | 30.66M | 28.13M | 37.09M | 60.03M | 80.19M | 100.75M | 117.98M | 143.19M | 165.5M | 110.09M | 128.53M | 142.59M |
| Cash Only | 30.66M | 28.13M | 37.09M | 60.03M | 80.19M | 100.75M | 117.98M | 143.19M | 165.5M | 110.09M | 128.53M | 142.59M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 0 | 1.14M | 922K | 1.13M | 964K | 1.03M | 909K | 1.13M | 954K | 1.2M | 1.01M | 1.53M |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 6.17M | 6.35M | 1.92M | 803K | 933K | 774K | 911K | 754K | 680K | 814K | 1.01M | 685K |
| Total Non-Current Assets | 3.13M | 3.35M | 3.39M | 2.75M | 3.7M | 3.81M | 4.03M | 3.46M | 4.3M | 4.52M | 4.58M | 3.59M |
| Property, Plant & Equipment | 1.85M | 2.07M | 2.2M | 2.36M | 2.51M | 2.67M | 2.88M | 3.11M | 3.16M | 3.36M | 3.43M | 3.23M |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 268K | 268K | 268K | 268K | 268K | 268K | 0 | 268K | 268K | 268K | 268K |
| Other Non-Current Assets | 1.28M | 1M | 924K | 117K | 924K | 876K | 883K | 357K | 867K | 891K | 876K | 84K |
| Total Assets | 39.96M | 42.33M | 45.74M | 67.7M | 89.94M | 111.47M | 128.16M | 150.72M | 172.55M | 117.56M | 136.84M | 151.81M |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | -55.58% | -62.03% | -64.31% | -55.08% | -47.87% | -5.18% | -6.35% | -0.72% | 6.41% | -35.64% | -32.31% | -31.71% |
| Total Current Liabilities | 18.31M | 19.9M | 18.29M | 19.49M | 16.05M | 13.72M | 11.04M | 15.72M | 12.98M | 10.88M | 10.36M | 10.68M |
| Accounts Payable | 5.59M | 5.54M | 5.2M | 4.66M | 5.26M | 5.02M | 3.84M | 3.88M | 6.64M | 4.46M | 4.26M | 4M |
| Days Payables Outstanding | 2.22K | 2.09K | 1.95K | 2.08K | 2.3K | 1.88K | 1.66K | 2.41K | 2.63K | 2.12K | 2.14K | 1.54K |
| Short-Term Debt | 788K | 768K | 0 | 0 | 0 | 678K | 0 | 0 | 627K | 613K | 559K | 515K |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 11.94M | 10.24M | 3M | 500K | 937K | 5.51M | 5M | 5.03M | 3.01M | 3.9M | 4.28M | 4.29M |
| Current Ratio | 2.01x | 1.96x | 2.32x | 3.33x | 5.37x | 7.84x | 11.24x | 9.37x | 12.96x | 10.39x | 12.77x | 13.88x |
| Quick Ratio | 2.01x | 1.96x | 2.32x | 3.33x | 5.37x | 7.84x | 11.24x | 9.37x | 12.96x | 10.39x | 12.77x | 13.88x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 20.73M | 20.84M | 1.03M | 1.2M | 1.32M | 1.47M | 1.65M | 1.84M | 1.98M | 2.16M | 2.27M | 2.27M |
| Long-Term Debt | 667K | 6.72M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 868K | 1.03M | 1.2M | 1.32M | 1.47M | 1.65M | 1.84M | 1.98M | 2.16M | 2.27M | 2.27M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 20.07M | 13.25M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 39.05M | 40.73M | 19.31M | 20.68M | 17.38M | 15.2M | 12.69M | 17.56M | 14.96M | 13.04M | 12.63M | 12.95M |
| Total Debt | 1.46M | 8.36M | 1.76M | 1.92M | 2.02M | 2.15M | 2.32M | 2.49M | 2.6M | 2.77M | 2.83M | 2.79M |
| Net Debt | -29.21M | -19.77M | -35.32M | -58.12M | -78.17M | -98.6M | -115.67M | -140.7M | -162.9M | -107.32M | -125.7M | -139.8M |
| Debt / Equity | 1.60x | 5.25x | 0.07x | 0.04x | 0.03x | 0.02x | 0.02x | 0.02x | 0.02x | 0.03x | 0.02x | 0.02x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -10.33x | -102.16x | - | - | - | - | - | - | - | - | - | - |
| Total Equity | 911K | 1.59M | 26.42M | 47.02M | 72.56M | 96.27M | 115.47M | 133.16M | 157.59M | 104.52M | 124.22M | 138.85M |
| Equity Growth % | -98.74% | -98.35% | -77.12% | -64.69% | -53.95% | -7.89% | -7.04% | -4.1% | 2.67% | -39.3% | -35.87% | -34.48% |
| Book Value per Share | 0.01 | 0.02 | 0.40 | 0.71 | 1.10 | 1.46 | 1.75 | 2.02 | 3.14 | 3.63 | 4.31 | 4.82 |
| Total Shareholders' Equity | 911K | 1.59M | 26.42M | 47.02M | 72.56M | 96.27M | 115.47M | 133.16M | 157.59M | 104.52M | 124.22M | 138.85M |
| Common Stock | 3.4M | 66K | 66K | 66K | 66K | 66K | 66K | 66K | 66K | 29K | 29K | 29K |
| Retained Earnings | -416.33M | -407.95M | -381.73M | -359.31M | -327.98M | -303.96M | -283.28M | -263.82M | -237.64M | -215.96M | -194.78M | -177.74M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -7.17M | -6.81M | -6.59M | -6.85M | -11M | -9.63M | -9.47M | -9.67M | -9.87M | -9.77M | -9.62M | -10.14M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |